ASHLEY CARR SCOGGINS: Open Payments
NPI 1730466798 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 81 payments from 19 companies in 2025. Trend: 2023 $1,052 · 2024 $1,343 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $489 |
| Amgen Inc. | 19 | $212 |
| Novo Nordisk Inc | 3 | $147 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| ANI Pharmaceuticals, Inc. | 3 | $90 |
| Dexcom, Inc. | 1 | $84 |
| Lilly USA, LLC | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| UCB, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
Products named: RINVOQ, Wegovy, KRYSTEXXA, VRAYLAR, PURIFIED CORTROPHIN GEL, Dexcom G6 Transmitter, SKYRIZI, MOUNJARO.
Industry payments across AL — which companies pay providers there.
